ArticleVaccines2023

Long-Term Immune Response Profiles to SARS-CoV-2 Vaccination and Infection in People with Multiple Sclerosis on Anti-CD20 Therapy.

Christina Woopen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.